Physician profile

John S Bruun

Surgical Critical Care · Nellis Afb, NV

NPI 1679547137

$13,900.32

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$355.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $8,824.81 2020
Acell, INC. $4,720.00 2020
Davol INC. $144.62 2023 Phasix Mesh
Prytime Medical Devices, INC. $84.81 2024 Er-Reboa Plus
Clr Medical, INC. $55.00 2024 Irrigator
Zimmer Biomet Holdings, INC. $48.38 2024 Gel-One Cross-Linked Hyaluronate
Baxter Healthcare $22.70 2023 Tisseel

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John S Bruun

$13,900.32

in general payments reported 2019-2025

Years
2020-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/837545/john-s-bruun

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.